Navigation Links
Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
Date:7/30/2008

expects to complete randomization and initial dosing in the NSCLC study shortly; initial data are anticipated in 2009.

-- In July 2008, HGS initiated dosing in the safety lead-in to a randomized Phase 2 trial of HGS-ETR1 in combination with Nexavar (sorafenib) in patients with advanced hepatocellular cancer (HCC), which accounts for 80- 90% of all liver cancers. The Company presented preclinical data that support the HCC study at the 2008 American Association for Cancer Research annual meeting in April.

In May 2008, HGS initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced solid tumors. Results of the study will also help identify the recommended dose for Phase 2 trials.

In April 2008, HGS reacquired rights to its TRAIL receptor antibodies HGS- ETR1 and HGS-ETR2 (lexatumumab) from GSK.

Darapladib: Phase 3 Plans Announced by GSK

In April 2008, GSK announced that it intends to advance darapladib to Phase 3 clinical trials as a potential treatment for atherosclerosis. Darapladib, a small-molecule inhibitor of Lp-PLA2, was discovered by GSK based on HGS technology. HGS will receive a 10% royalty on worldwide sales of darapladib if it is commercialized, and also has a 20% co-promotion option in North America and Europe.

CONFERENCE CALL

HGS management will hold a conference call to discuss this announcement today at 5 PM Eastern Time. Investors may listen to the call by dialing 888-686-9685 or 913-312-0412, passcode 4551709, five to 10 minutes before the start of the call. A replay of the conference call will be available within a few hours after the call ends. Investors may listen to the replay by dialing 888-203-1112 or 719-457-0820, confirmation code 4551709. Today's conference call also will be webcast and can be accessed at http://www.hgsi.com. Investors interested
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
2. Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results
3. New map IDs the core of the human brain
4. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
5. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment
6. China Biologic Products Announces SFDA Approval for the Production and Sale of Human Albumin 12.5g/vial (25%, 50 ml)
7. MAP Pharmaceuticals Appoints Marco Rosa Vice President of Human Resources
8. Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
9. Robots moving closer to humans
10. Highest Replikin Concentrations and Cyclical Behavior Related to Human Mortality Are Found in Malaria Trypanosomes
11. Human Genome Sciences Names Kevin P. McRaith Vice President, Hepatology Franchise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Mo. From cell phones to cars and ... life. Scientists and technology companies constantly are seeking ... for the first time using a water-based solution, ... a long-lasting and more efficient nuclear battery that ... a reliable energy source in automobiles and also ...
(Date:9/16/2014)... Cardioxyl Pharmaceuticals, Inc. announced today ... to be effective in animal models following oral (capsule) ... infusions that could pave the way for convenient outpatient ... at the Heart Failure Society of America,s (HFSA) 18 ... Vegas . The research, conducted in ...
(Date:9/16/2014)... , Sept. 16, 2014  The Council ... entrepreneurial support organization in the country, today released ... Report . It showed that ... North Carolina startups in the technology, ... more global investment from a variety of sources. Significant ...
(Date:9/16/2014)... September 16, 2014 Convoy Therapeutics, ... and effective products to treat patients directly at ... a proprietary SPACEā„¢ Technology Platform announced today that ... will present at the White Hat Life Science ... Hyatt Regency Phoenix. In addition, interested individuals ...
Breaking Biology Technology:Cardioxyl Presents Oral Heart Failure Treatment Data For Its Experimental HNO Prodrug At HFSA 18th Annual Scientific Meeting 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 2CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 3CED's Mid-Year Update to its Innovators Report Shows NC Startups Attracting Investment From Across the Globe with Several High-Profile Investment Deals, IPOs and Acquisitions Signaling Strength of Entrepreneurial Sector 4Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 2Convoy Therapeutics to Present at WhiteHat Investor Conference September 18, 2014 3
... NIH funds human ... ... announced today that it is one of the recipients in a 4-year $1.95M grant from ... evaluate Cell Sense, the Company’s fluorocarbon-based magnetic resonance imaging (MRI) cell tracking reagent, for clinical ...
... vital in helping to save up to 90 per cent ... to scientists. The research team led by Durham ... the UK) looked at the effects of climate change on ... on the network of sites designated for them (termed Important ...
... N.J., June 1 BD (Becton, Dickinson and Company) (NYSE: BDX ), a ... conferences in June: , , Goldman Sachs 30th ... 11:40 a.m. EDT, ... 11, 2009, 10:00 a.m. EDT, , ...
Cached Biology Technology:Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use 2Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use 3Nature parks can save species as climate changes 2Nature parks can save species as climate changes 3
(Date:9/16/2014)... take up residence in and on the human body ... according to new research at Washington University School of ... individuals carry about five types of viruses on their ... Biology . The study is the first comprehensive analysis ... , The research was conducted as part of ...
(Date:9/16/2014)... The meteorite impact that spelled doom for the dinosaurs ... flowering plants to a much greater extent than their ... researchers. The results are published in the journal ... a treasure trove of thousands of fossilized leaves of ... team was able to reconstruct the ecology of a ...
(Date:9/16/2014)... school year, a new football season and another commercial ... SpaceX,s Dragon spacecraft is scheduled to blast off to ... of the company,s fourth contracted mission to the complex. ... suite of research investigations sponsored by the Center for ... role of managing the U.S. National Laboratory on the ...
Breaking Biology News(10 mins):Healthy humans make nice homes for viruses 2Healthy humans make nice homes for viruses 3Meteorite that doomed dinosaurs remade forests 2Meteorite that doomed dinosaurs remade forests 3Meteorite that doomed dinosaurs remade forests 4CASIS research set for launch aboard SpaceX mission to space station 2CASIS research set for launch aboard SpaceX mission to space station 3
... BROOK, NY, February 20, 2013As the nations of the ... trade in endangered sharks in early March, a team ... the oceanic whitetip shark regularly crosses international ... apex predator within their own maritime borders may therefore ...
... The University of Texas at Arlington are pioneering a new ... make liquid methanol fuel by using copper oxide nanowires and ... expensive than previous methods to convert the greenhouse gas associated ... interim associate vice president for research at UT Arlington and ...
... from 375 past teen participants in a Canadian biotechnology ... -- show a majority of respondents were influenced by ... offering a model for countries worldwide to advance their ... of 375 past participants by Bioscience Education Canada, which ...
Cached Biology News:New research on migratory behavior of oceanic whitetip sharks can help shape conservation strategies 2New research on migratory behavior of oceanic whitetip sharks can help shape conservation strategies 3Researchers say sunlight yields more efficient carbon dioxide to methanol model 2'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 2'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 3'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 4'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 5'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 6'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 7'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 8'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 9'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 10'Inspiring' teens with 'research virus': Expert-mentored bioscience contest proves a powerful vector 11
Acetylcholinesterase from human and monkey....
...
... Dye runs faster than Bromophenol blue,or ... gels.,Orange G dye migrates with DNA ... migration at this size,prevents the obscuring ... the front of DNA migration.,The Orange ...
... solution, Type I is ... and agarose gel electrophoresis ... offers the advantage of ... blue and xylene cyanole). ...
Biology Products: